Results 71 to 80 of about 16,337 (195)

PB1897: DISCONTINUATION OF IMATINIB IN PATIENTS FOLLOWED FOR CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE

open access: yesHemaSphere, 2022
Y. Bouchakor Moussa   +8 more
doaj   +1 more source

GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2009
Sickle cell disease (SCD) and ß-thalassemia represent the most common hemoglobinopathies caused, respectively, by the alteration of structural features or deficient production of the ß-chain of the Hb molecule.
Laura Breda   +2 more
doaj   +1 more source

Iron Overload: Pathophysiology, Diagnosis and Monitoring

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 4, Page 747-756, August 2026.
ABSTRACT Iron overload is associated with significant health risks, underscoring the importance of understanding its pathophysiology as well as establishing accurate diagnostic and monitoring methods. Chronic iron overload is associated with either genetic disorders characterized by excessive iron accumulation (hereditary hemochromatosis), or is ...
Elena Chatzikalil   +3 more
wiley   +1 more source

The association between inflammatory markers in routine blood counts at 1 year and attention‐deficit/hyperactivity disorder (ADHD): A case–control study

open access: yesJournal of Child Psychology and Psychiatry, Volume 67, Issue 8, Page 1404-1411, August 2026.
Background Attention‐deficit/hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder marked by persistent patterns of inattention, disorganization, hyperactivity, and impulsivity. Increasing evidence implicates immune‐inflammatory processes in its etiology, with observed associations between ADHD and infectious diseases, allergic ...
Eugene Merzon   +11 more
wiley   +1 more source

Changing the Sickle Cell Nutrition Integration Narrative: Qualitative Perspectives From Sickle Cell Service Users/Carers About Nutritional Care

open access: yesJournal of Human Nutrition and Dietetics, Volume 39, Issue 4, August 2026.
This novel qualitative study provides primary data that reflects the sickle cell service user/carer voice about the changes needed to redefine and integrate nutritional management in standard SCD care. ABSTRACT Introduction Nutrition is not currently integrated into standard care provision in sickle cell disease (SCD) impacting patients experience ...
Claudine Matthews   +3 more
wiley   +1 more source

IMPORTANCE OF IMPLEMENTING PROGRAM SCREENING NEONATAL HEMOGLOBINOPATHIES IN CAPE VERDE

open access: yesNational Journal of Medical Research, 2015
Hemoglobinopathies are hereditary blood diseases, the most frequent sickle cell anemia. To date not have curative treatment, unless bone marrow transplant, which has yet been carried out experimentally.
Leonel Barbosa Gonçalves
doaj  

A study of hemoglobinopathies and hemoglobin variants by high-performance liquid chromatography and correlation with red blood cell indices in antenatal mothers

open access: yesAsian Journal of Medical Sciences
Background: Hemoglobinopathies are the most commonly inherited red cell disorder around the world. In India, hemoglobinopathies show wide variation of prevalence in different regions and different populations.
Arnab Sinha   +2 more
doaj   +1 more source

Erythrocytapheresis as a novel treatment option for adult patients with pyruvate kinase deficiency

open access: yesHaematologica, 2020
Rawia F.G. Jensen   +4 more
doaj   +1 more source

Abstract Introduction of a Novel Pathogenic Variant (c.1684G>A) in The SOX5 Gene Associated With Lamb–Shaffer Syndrome in a Family From North of Iran

open access: yesCase Reports in Clinical Practice
So far, different types of SOX5 variants have been reported in patients with LAMSHF syndrome, which are mainly clustered in the HMG domain. The LAMSHF syndrome has a broad variety of clinical manifestations such as developmental delay, speech delay ...
Akbar Amirfiroozy   +4 more
doaj   +1 more source

Hemoglobinopathies

open access: yesJapanese Journal of Transfusion and Cell Therapy, 2022
Taiju Utsugisawa, Hitoshi Kanno
openaire   +2 more sources

Home - About - Disclaimer - Privacy